If you made any changes in Pure, your changes will be visible here soon.

Research Output 1967 2019

Filter
Review article
2018
4 Citations (Scopus)

Lipoproteins for therapeutic delivery: Recent advances and future opportunities

Raut, S., Dasseux, J. L., Sabnis, N. A., Mooberry, L. & Lacko, A., 1 Jan 2018, In : Therapeutic Delivery. 9, 4, p. 257-268 12 p.

Research output: Contribution to journalReview article

Lipoproteins
Neoplasms
Triglycerides
Therapeutics
Cholesterol
3 Citations (Scopus)

Reconstituted HDL: Drug delivery platform for overcoming biological barriers to cancer therapy

Raut, S., Mooberry, L., Sabnis, N., Garud, A., Dossou, A. S. & Lacko, A., 15 Oct 2018, In : Frontiers in Pharmacology. 9, OCT, 01154.

Research output: Contribution to journalReview article

Pharmaceutical Preparations
Neoplasms
Nanoparticles
Therapeutics
Technology
2016
27 Citations (Scopus)

Targeting the SR-B1 receptor as a gateway for cancer therapy and imaging

Mooberry, L. K., Sabnis, N. A., Panchoo, M., Nagarajan, B. & Lacko, A. G., 1 Jan 2016, In : Frontiers in Pharmacology. 7, DEC, 466.

Research output: Contribution to journalReview article

Scavenger Receptors
CD36 Antigens
Neoplasms
Therapeutics
Cholesterol Esters
2014
12 Citations (Scopus)

Targeted nanoparticles for pediatric leukemia therapy

Basha, R., Sabnis, N., Heym, K., Bowman, W. P. & Lacko, A. G., 1 Jan 2014, In : Frontiers in Oncology. 4 MAY, 101.

Research output: Contribution to journalReview article

Nanoparticles
Leukemia
Pediatrics
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
2013
10 Citations (Scopus)

The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer

Johnson, R., Sabnis, N., McConathy, W. J. & Lacko, A. G., 18 Jun 2013, In : Pharmaceutics. 5, 2, p. 353-370 18 p.

Research output: Contribution to journalReview article

Triple Negative Breast Neoplasms
Nanotechnology
Breast Neoplasms
Survival Rate
Therapeutics
120 Citations (Scopus)

The role of cholesterol metabolism and cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer therapeutics

Cruz, P. M. R., Mo, H., McConathy, W. J., Sabnis, N. & Lacko, A. G., 16 Oct 2013, In : Frontiers in Pharmacology. 4 SEP, Article 119.

Research output: Contribution to journalReview article

Carcinogenesis
Cholesterol
Neoplasms
Therapeutics
Bile Acids and Salts
2012
32 Citations (Scopus)

Drug delivery via lipoprotein-based carriers: Answering the challenges in systemic therapeutics

Sabnis, N. & Lacko, A. G., 1 May 2012, In : Therapeutic Delivery. 3, 5, p. 599-608 10 p.

Research output: Contribution to journalReview article

Lipoproteins
Pharmaceutical Preparations
Therapeutics
Neoplasms
Drug Carriers
2007
61 Citations (Scopus)

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

Lacko, A. G., Nair, M. P., Prokai, L. & McConarthy, W. J., 1 Nov 2007, In : Expert Opinion on Drug Delivery. 4, 6, p. 665-675 11 p.

Research output: Contribution to journalReview article

Lipoproteins
Pharmaceutical Preparations
Neoplasms
Drug Compounding
Drug Carriers
4 Citations (Scopus)

Recent developments and patenting of lipoprotein based formulations.

Lacko, A. G., Stewart, D. R., McClain, R., Prokai, L. & McConathy, W. J., 1 Jan 2007, In : Recent patents on drug delivery & formulation. 1, 2, p. 143-145 3 p.

Research output: Contribution to journalReview article

Lipoproteins
Drug delivery
Pharmaceutical Preparations
Solubility
Chemotherapy
1992
7 Citations (Scopus)

Physiologic role and clinical significance of reverse cholesterol transport

Bleicher, J. M. & Lacko, A. G., 1 Jan 1992, In : Journal of the American Osteopathic Association. 92, 5, p. 625-632 8 p.

Research output: Contribution to journalReview article

Cholesterol
Atherosclerosis
Cholesterol Ester Transfer Proteins
Phosphatidylcholine-Sterol O-Acyltransferase
HDL Lipoproteins